Author

Lucy Spears

Observed names: L Spears, L. Spears

Institutions: University of Southern California, USC Norris Comprehensive Cancer Center

Observed institutions: University of Southern California, USC Norris Comprehensive Cancer Center

OpenAlex ID: A5059634145

Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.

1999 · F Wang, E Bade, et al. · PubMed · 221

A Phase I Trial of an HLA-A1 Restricted MAGE-3 Epitope Peptide with Incomplete Freundʼs Adjuvant in Patients with Resected High-Risk Melanoma

1999 · Jeffrey S. Weber, Flora L. Hua, et al. · Journal of Immunotherapy · 125

A phase I study of a HER2/neu bispecific antibody with granulocyte-colony-stimulating factor in patients with metastatic breast cancer that overexpresses HER2/neu

1999 · V. Pullarkat, Y. Deo, et al. · Cancer Immunology Immunotherapy · 55

Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-m.

1997 · W D Quan, G E Dean, et al. · Journal of Clinical Oncology · 36

Sustained regression of a primary choroidal melanoma under the influence of a therapeutic melanoma vaccine.

1994 · M S Mitchell, P E Liggett, et al. · Journal of Clinical Oncology · 13

Works count: 5

Citation count: 450

H-index: 5

I10-index: 5